High-yield reporting fields for suspected semaglutide-related vaginal symptoms include: dose and escalation dates, concomitant SGLT2 inhibitor use, antibiotic/antifungal use, menopausal status/HRT, diabetes control markers, symptom description with onset/offset, objective test results (pH, microscopy/NAAT), and dechallenge/rechallenge outcomes if they occur
However, studies have also found that GLP-1 therapies can result in the loss of muscle mass
This information can support a more personalized conversation with your provider about which GLP-1 formulation, titration schedule, or adjunctive strategies may align best with your genetic background
Side effects can feel discouraging when youre trying something new, but with clear guidance and support, most adults adapt smoothly
Step 2: Complete Advanced Lab Testing Before initiating peptide therapy for men, comprehensive lab work is essential